Article
Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease.
The Journal of clinical investigation - 16 Aug 2021
Kirk Jonathan A, Cheung Joseph Y, Feldman Arthur M
Abstract excerpt
Bcl2-associated athanogene-3 (BAG3) is expressed ubiquitously in humans, but its levels are highest in the heart, the skeletal muscle, and the central nervous system; it is also elevated in many cancers. BAG3's diverse functions are supported by its multiple protein-protein binding domains, which couple with small and large heat shock proteins, members of the Bcl2 family, other antiapoptotic proteins, and various...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
